|
Video: What is a Stock Split?
|
|
VolitionRx is an epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. According to our VolitionRx stock split history records, VolitionRx has had 0 splits. | |
|
VolitionRx (VNRX) has 0 splits in our VolitionRx stock split history database.
Looking at the VolitionRx stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VolitionRx shares, starting with a $10,000 purchase of VNRX, presented on a split-history-adjusted basis factoring in the complete VolitionRx stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$2.42 |
|
End price/share: |
$0.60 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-75.21% |
|
Average Annual Total Return: |
-13.01% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,480.43 |
|
Years: |
10.00 |
|
|
|
|
|